AKISOSTEM BIOSTRATEGIES
Archisostem BioStrategies is a research and development company.
AKISOSTEM BIOSTRATEGIES
Industry:
Alternative Medicine Health Care Medical
Founded:
2019-02-28
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Total Employee:
251+
Status:
Active
Total Funding:
2 B KRW
Similar Organizations
ADITEC Vaccine Consortium
ADITEC vaccine consortium is a research institutions and biotech company.
BLISTER EXPRESS
BLISTER EXPRESS is a pharmaceutical research and development company.
Dream Company
Dream Company is a health care research and development company.
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
Joinn Laboratories
Joinn Laboratories (China) operates as a medicines development company.
T.Pharm
T.Pharm is the production, sales, research, and development of drugs.
Yuanmo Health
Yuanmo Health focuses on the construction of medical and health management system research and development.
Investors List
Mira Partners
Mira Partners investment in Series A - Akisostem BioStrategies
TAP Angel Partners
TAP Angel Partners investment in Series A - Akisostem BioStrategies
BlissVine Ventures
BlissVine Ventures investment in Series A - Akisostem BioStrategies
Seoul Techno Holdings
Seoul Techno Holdings investment in Series A - Akisostem BioStrategies
More informations about "Akisostem BioStrategies"
Akisostem BioStrategies - Crunchbase Company Profile โฆ
Organization. Akisostem BioStrategies . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. Archisostem โฆSee details»
Akisostem BioStrategies - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... Series A - Akisostem BioStrategies โ Seoul โฆSee details»
ACESOSTEM BIOSTRATEGIES INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACESOSTEM BIOSTRATEGIES INC. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
AcesoStem Biostrategies - PitchBook
AcesoStem Biostrategies General Information Description. Developer of drugs and therapeutics intended to provide treatment for rotator cuff disease. The โฆSee details»
AcesoStem Biostrategies - Products, Competitors, Financials, โฆ
AcesoStem Biostrategies specializes in patented technology related to the smumf cell, an umbilical cord-derived, regenerative medical platform cell that was transferred from the Seoul โฆSee details»
GC Cell signs CDMO Agreement with Archesostem BioStrategies
Mar 30, 2023 [ํ๋ด์ค=์ด๊ถ๊ตฌ ๊ธฐ์] GC Cell announced on the 30th that it had signed a CDMO contract with Archisostem BioStrategies (hereafter referred to as Akisostem). Archisostem was โฆSee details»
AcesoStem Biostrategies Stock Price, Funding, Valuation, Revenue ...
See AcesoStem Biostrategies funding rounds, investors, investments, exits and more. Evaluate their financials based on AcesoStem Biostrategies's post-money valuation and revenue.See details»
Akisostem BioStrategies - Updates, News, Events, Signals & Triggers
Organization. Akisostem BioStrategies . Connect to CRM . Save . Summary Financials People Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity โฆSee details»
GC Cell, CDMO Contract With Akisostem BioStrategies - CMOCRO
Through this contract, GC Cell will conduct quality tests such as manufacturing, storage, and characterization of Akisostem's umbilical cord mesenchymal stem cells for approximately three โฆSee details»
Akisostem BioStrategies: ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
ไบ่งฃAkisostem BioStrategiesๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
Walter Acosta - Chief Scientific Officer - BioStrategies LC - LinkedIn
Chief Scientific Officer BioStrategies LC · Experience: BioStrategies LC · Education: Arkansas State University · Location: Arkansas · 500+ connections on LinkedIn. View Walter Acostaโs ...See details»
Carole Cramer - President - BioStrategies LC - LinkedIn
President and Co-Founder, BioStrategies · President and Co-Founder of BioStrategies, a preclinical biotech start-up focused on delivering biologics to hard-to-treat tissues and โฆSee details»
Akisostem BioStrategies - Crunchbase
Archisostem BioStrategies is a research and development company. Start Free Trial . Chrome ExtensionSee details»
Firm | SBIR
BioStrategies LC has developed an enzyme delivery technology based on the plant lectin RTB which greatly enhances delivery of fused enzymes to hard-to-treat cells and tissues including โฆSee details»
AcesoStem Biostrategies corporate identity - d note
AcesoStem Biostrategies corporate identity ์ฐ๋ฆฌ๊ฐ ํํ ๋ ์ฌ๋ฆฌ๋ ์ค๊ธฐ์ธํฌ์ ๋ชจ์ต์ ์ค์ ์ค๊ธฐ์ธํฌ์ ๋ชจ์ต๊ณผ๋ ๋ค๋ฆ ๋๋ค. ๊ธฐ๋ ์ด์, ์ธ์ ๋ ์์ธก๊ฐ๋ฅํ ์์ค์ ๋์ด์๋ ์น๋ฃ์ ๋ต์ โฆSee details»
biostrategies Group 2025 Company Profile: Valuation, Investors ...
Biostrategies Group General Information Description. Provider of consulting services catering to the biopharma industry. The company specializes in developing commercial strategies for new โฆSee details»
Series A - Akisostem BioStrategies - 2022-02-06 - Crunchbase
Akisostem BioStrategies raised $1668906 on 2022-02-06 in Series A. Start Free Trial . Chrome ExtensionSee details»
bioStrategies Group - 2025 Company Profile - Tracxn
Mar 28, 2025 bioStrategies Group is an acquired company based in Chicago (United States), founded in 1995. It operates as a Provider of biopharma consulting services . The company โฆSee details»
Charles River Associates buys BioStrategies Group - Consulting.us
Dec 1, 2022 Charles River Associates has acquired BioStrategies Group (stylized as โbioStrategies Groupโ), a Chicago-based life sciences consulting firm. Founded in 1995, โฆSee details»
ADITEC Vaccine Consortium - Crunchbase Company Profile
Alternatives and possible competitors to ADITEC Vaccine Consortium may include Akisostem BioStrategies, Caliper Technologies, and Israeli Immunology Society. Browse By: โฆSee details»